HSE - PCRS

Application Details

HSE Application ID

HSE100086

HTA Number

26001

HTA Link

https://www.ncpe.ie/naldemedine-rizmoic-hta-id-26001/

Drug

naldemedine

Brand

Rizmoic®

Applicant

Viatris

Indication Applied For

Indicated for the treatment of opioid-induced constipation (OIC) in adult patients who have
previously been treated with a laxative.

Application Date

06/01/2026

Marketing Authorisation Date

18/02/2019

Application Status

Proposal from Applicant Under Review

23/04/2026

Awaiting Proposal from Applicant

23/04/2026

Applicant Meeting Held with CPU

23/04/2026

Awaiting Proposal from Applicant

30/01/2026

Rapid Review Completed

23/01/2026

Rapid Review Commissioned

06/01/2026

Pricing and Reimbursement Application Complete

06/01/2026